London Futurists

Pioneering AI drug development, with Alex Zhavoronkov


Listen Later

This episode discusses progress at Insilico Medicine, the AI drug development company founded by our guest, longevity pioneer Alex Zhavoronkov.

1.20 In Feb 2022, Insilico got an IPF drug into phase 1 clinical trials: a first for a wholly AI-developed drug
1.50  Insilico is now well-funded; its software is widely used in the pharma industry
2.30 How drug development works. First you create a hypothesis about what causes a disease
4.00 Pandaomics is Insilico’s software to generate hypotheses. It combines 20+ AI models, and huge public data repositories
6.00 This first phase is usually done in academia. It usually costs $ billions to develop a hypothesis. 95% of them fail
6.50 The second phase is developing a molecule which might treat the disease
7.15 This is the job of Insilico’s Chemistry 42 platform
7.30 The classical approach is to test thousands of molecules to see if they bind to the target protein
7.50 AI, by contrast, is able to "imagine" a novel molecule which might bind to it
8.00 You then test 10-15 molecules which have the desired characteristics
8.20 This is done with a variety of genetic algorithms, Generative Adversarial Networks (GANs), and some Transformer networks
8.35 Insilico has a “zoo” of 40 validated models
10.40 Given the ten-fold improvement, why hasn’t the whole drug industry adopted this process?
10.50 They do all have AI groups and they are trying to change, but they are huge companies, and it takes time
11.50 Is it better to invent new molecules, or re-purpose old drugs, which are already known to be safe in humans?
13.00 You can’t gain IP with re-purposed drugs: either somebody else “owns” them, or they are already generic
15.00 The IPF drug was identified during aging research, using aging clocks, and a deep neural net trained on longitudinal data
17.10 The third phase is where Insilico’s other platform, InClinico, comes into play
17.35 InClinico predicts the results of phase 2 (clinical efficacy) trials
18.15 InClinico is trained on massive data sets about previous trials
19.40 InClinico is actually Insilico’s oldest system. Its value has only been ascertained now that some drugs have made it all the way through the pipeline
22.05 A major pharma company asked Insilico to predict the outcome of ten of its trials
22.30 Nine of these ten trials were predicted correctly
23.00 But the company decided that adopting this methodology would be too much of an upheaval; it was unwilling to rely on outsiders so heavily
24.15 Hedge funds and banks have no such qualms
24.25 Insilico is doing pilots for their investments in biotech startups
26.30 Alex is from Latvia originally, studied in Canada, started his career in the US, but Insilico was established in Hong Kong. Why?
27.00 Chinese CROs, Contract Research Organisations, enable you to do research without having your own wetlab 
28.00 Like Apple, Insilico designs in the US and does operations in China. You can also do clinical studies there
28.45 They needed their own people inside those CROs, so had to be co-located

Real Talk About Marketing

An Acxiom podcast where we discuss marketing made better, bringing you real...

Listen on: Apple Podcasts   Spotify

Digital Disruption with Geoff Nielson
Discover how technology is reshaping our lives and livelihoods.

Listen on: Apple Podcasts   Spotify

...more
View all episodesView all episodes
Download on the App Store

London FuturistsBy London Futurists

  • 4.7
  • 4.7
  • 4.7
  • 4.7
  • 4.7

4.7

9 ratings


More shows like London Futurists

View all
In Our Time by BBC Radio 4

In Our Time

5,389 Listeners

BBC Inside Science by BBC Radio 4

BBC Inside Science

401 Listeners

Making Sense with Sam Harris by Sam Harris

Making Sense with Sam Harris

26,462 Listeners

a16z Podcast by Andreessen Horowitz

a16z Podcast

1,032 Listeners

The Gray Area with Sean Illing by Vox

The Gray Area with Sean Illing

10,694 Listeners

Azeem Azhar's Exponential View by Azeem Azhar

Azeem Azhar's Exponential View

613 Listeners

Google DeepMind: The Podcast by Hannah Fry

Google DeepMind: The Podcast

198 Listeners

Dwarkesh Podcast by Dwarkesh Patel

Dwarkesh Podcast

407 Listeners

Big Technology Podcast by Alex Kantrowitz

Big Technology Podcast

442 Listeners

The Rest Is Politics by Goalhanger

The Rest Is Politics

3,276 Listeners

The News Agents by Global

The News Agents

981 Listeners

Moonshots with Peter Diamandis by PHD Ventures

Moonshots with Peter Diamandis

477 Listeners

The Rest Is Politics: Leading by Goalhanger

The Rest Is Politics: Leading

987 Listeners

The Rest Is Money by Goalhanger

The Rest Is Money

220 Listeners

The Rest Is Politics: US by Goalhanger

The Rest Is Politics: US

2,285 Listeners